VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 739 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $60,078,000 | +93.7% | 19,000 | +90.0% | 5.36% | +18.3% |
| Q4 2023 | $31,010,000 | +15.2% | 10,000 | 0.0% | 4.53% | +18.7% |
| Q3 2023 | $26,910,000 | +33.4% | 10,000 | -96.4% | 3.82% | +107.9% |
| Q2 2023 | $20,173,700 | +131.0% | 274,000 | +1.5% | 1.84% | +30.8% |
| Q1 2023 | $8,734,500 | +60.4% | 270,000 | +42.1% | 1.40% | +13.0% |
| Q4 2022 | $5,445,400 | -46.5% | 190,000 | -26.9% | 1.24% | -29.7% |
| Q3 2020 | $10,182,000 | -44.5% | 260,000 | -48.0% | 1.77% | -70.5% |
| Q2 2020 | $18,340,000 | +368.2% | 500,000 | +194.1% | 5.99% | +51.8% |
| Q1 2020 | $3,917,000 | -27.7% | 170,000 | -8.1% | 3.95% | +21.2% |
| Q4 2019 | $5,417,000 | – | 185,000 | – | 3.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |